Ocular surface disease is characterized by tear film instability and histopathologic and clinical changes of the ocular surface. Glaucoma patients often suffer from ocular surface disease caused by the chronic use of preserved medical treatment to reduce intraocular pressure. Benzalkonium chloride is the preservative most frequently used in glaucoma medications. Its effect on tear film, conjunctiva and cornea and the consequences in glaucoma management are discussed in this mini-review.
Tear film, conjunctival and corneal modifications induced by glaucoma treatment / Roberti, G., Tanga, L., Manni, G., Riva, I., Verticchio, A.c., Berardo, F., Carnevale, C., Oddone, F.. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - 26:22(2019), pp. 4253-4261. [10.2174/0929867326666190517111823]
Tear film, conjunctival and corneal modifications induced by glaucoma treatment
Roberti GPrimo
;Manni G;
2019
Abstract
Ocular surface disease is characterized by tear film instability and histopathologic and clinical changes of the ocular surface. Glaucoma patients often suffer from ocular surface disease caused by the chronic use of preserved medical treatment to reduce intraocular pressure. Benzalkonium chloride is the preservative most frequently used in glaucoma medications. Its effect on tear film, conjunctiva and cornea and the consequences in glaucoma management are discussed in this mini-review.| File | Dimensione | Formato | |
|---|---|---|---|
|
Roberti_Tear film_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
